A world-first treatment for Creutzfeldt-Jakob disease (CJD), developed by scientists at the Medical Research Council (MRC) Prion Unit at UCL, has shown «very encouraging» early results following its use in six patients at University College London Hospitals (UCLH) NHS Foundation Trust.
World-first Creutzfeldt-Jakob disease treatment shows promising early results
A world-first treatment for Creutzfeldt-Jakob disease (CJD), developed by scientists at the Medical Research Council (MRC) Prion Unit at UCL, has shown "very encouraging" early results following its use in six patients at University College London Hospitals (UCLH) NHS Foundation Trust.